Trials / Unknown
UnknownNCT04481542
Aortic Dissection With 4-dimensional Phase-contrast Magnetic Resonance Imaging
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Chang Gung Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
We prospectively collected information on consecutive patients who had been evaluated using 4D PC-MRI for aortic pathology in a tertiary hospital between April 2018 and Feb 2020. Patients were eligible for inclusion in the study if they had a clinical indication for CTA of aortic dissections.
Detailed description
The exclusion criteria were non-MRI-compatible ferromagnetic devices and pregnancy. In addition, patients with poor compliance and with unstable status that prevented them from lying down for the MRI protocol were excluded. Initially, 26 patients evaluated. One patient was excluded due to fever at the scheduled time, and another was unable to lie down due to complicated spine disease. All patients underwent CTA scan on a 64-slice multidetector scanner (Somatom Sensation 64; Siemens Healthcare, Erlangen, Germany) with the intravenous administration of contrast media, followed by 4D PC-MRI to assess aortic pathology
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | MRI | check MRI quality in aorta |
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2020-02-12
- Completion
- 2025-12-12
- First posted
- 2020-07-22
- Last updated
- 2020-07-22
Locations
1 site across 1 country: Taiwan
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04481542. Inclusion in this directory is not an endorsement.